Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ DBM Global to Pay Cash Dividend (GlobeNewswire EN) +++ INNOVATE CORP Aktie -4,76%

PFIZER Aktie

 >PFIZER Aktienkurs 
21.05 EUR    -0.1%    (TradegateBSX)
Ask: 21.05 EUR / 0 Stück
Bid: 21.025 EUR / 0 Stück
Tagesumsatz: 74584 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
PFIZER Aktie über LYNX handeln
>PFIZER Performance
1 Woche: +0,3%
1 Monat: -5,4%
3 Monate: -9,9%
6 Monate: -3,1%
1 Jahr: -3,7%
laufendes Jahr: -1,1%
>PFIZER Aktie
Name:  PFIZER INC. DL-,05
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US7170811035 / 852009
Symbol/ Ticker:  PFE (Frankfurt) / PFE (NYSE)
Kürzel:  FRA:PFE, ETR:PFE, PFE:GR, NYSE:PFE
Index:  S&P500
Profil:  Pfizer Inc. is a leading biopharmaceutical company that discovers, develops, manufactures, markets, distributes, and sells prescription drugs and vaccines worldwide. Operating in segments including Biopharma, PC1, and Pfizer Ignite, it focuses on key..
>Volltext..
Marktkapitalisierung:  118527.08 Mio. EUR
Unternehmenswert:  163409.75 Mio. EUR
Umsatz:  55510.74 Mio. EUR
EBITDA:  20806.78 Mio. EUR
Nettogewinn:  6544.86 Mio. EUR
Gewinn je Aktie:  1.15 EUR
Schulden:  56510.23 Mio. EUR
Liquide Mittel:  1493.09 Mio. EUR
Operativer Cashflow:  10507.72 Mio. EUR
Bargeldquote:  0.38
Umsatzwachstum:  -5.09%
Gewinnwachstum:  -11.15%
Dividende je Aktie:  1.47 EUR
Dividendenrendite:  7.25%
Dividendenschätzung:  7.24%
Div. Historie:  08.05.26 - 0.364726€
23.01.26 - 0.363694€
>weitere anzeigen...
Insiderhandel 1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 45.026 Euro.
Suchwörter:  PFIZER
Letzte Datenerhebung:  08.07.26
>PFIZER Kennzahlen
Aktien/ Unternehmen:
Aktien: 5699.44 Mio. St.
Frei handelbar: 99.89%
Rückkaufquote: -
Mitarbeiter: 75000
Umsatz/Mitarb.: 0.73 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 19.12%
Bewertung:
KGV: 18.66
KGV lG: 8.16
KUV: 2.15
KBV: 1.54
PEG-Ratio: -
EV/EBITDA: 7.85
Rentabilität:
Bruttomarge: 65.16%
Gewinnmarge: 11.81%
Operative Marge: 27.08%
Managementeffizenz:
Gesamtkaprendite: 3.6%
Eigenkaprendite: 8.29%
 >PFIZER Anleihen 
>PFIZER Peer Group
 
08.07.26 - 16:45
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
 
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock....
08.07.26 - 14:42
Buy or Goodbye?: Rheinmetall, Amazon, Apple und Pfizer – Die Analystenstimmen des Tages (Wallstreet-Online)
 
Rheinmetall, Amazon, Apple und Pfizer: Die wichtigsten Analysten-Updates im Überblick....
08.07.26 - 13:39
Pfizer-Aktie im Niemandsland – Merck & Co läuft Pharma-Konzern den Rang ab (Der Aktionaer)
 
Die großen US-amerikanischen Pharma-Aktien geben derzeit ein unterschiedliches Bild ab. Während das Papier von Eli Lilly ein neues Rekordhoch markiert hat und AbbVie knapp darunter notiert, schlägt sich dahinter die Aktie von Merck & Co deutlich besser als die des Wettbewerbers Pfizer....
08.07.26 - 12:03
Pfizer Neutral (DPA-AFX)
 
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Pfizer von 30 auf 28 US-Dollar gesenkt und die Einstufung auf "Neutral" belassen. Seine Schätzungen für die Quartalszahlen am 4. August lägen weitgehend im Rahmen der Markterwartungen, ......
07.07.26 - 21:48
"I-Beams Bending Like Cigarettes": Former Pfizer HQ Tower In Midtown At Risk Of Collapse (ZeroHedge)
 
"I-Beams Bending Like Cigarettes": Former Pfizer HQ Tower In Midtown At Risk Of Collapse Dramatic video from inside the former Pfizer headquarters tower in Midtown Manhattan shows large I-beams buckling, and officials are warning of a possible collapse. The 33-story high-rise at 235 East 42nd Street is undergoing a major office-to-residential conversion, one of the largest projects of its kind in the New York City metro area. WATCH: New York City's biggest office-to-residential conversion just hit an unexpected obstacle. Buckling columns and falling bricks forced an evacuation at the former Pfizer headquarters. pic.twitter.com/anXDOmBSfw — The Real Deal (@trdny) July 7, 2026 Local media outlet Pix 11 cited the FDNY, which said floors 21 through 26 have caved in, and major cracks and sagging floors were seen throughout the tower. Video shows two columns buckled inside a Midtown building under construction. Dozens were evacuated and multiple streets were closed at the height of rush...
07.07.26 - 18:12
Opinion: Pfizer′s Dividend Is Riskier Than You Might Think (Fool)
 
A 7% dividend yield will grab your attention, but be sure to read the fine print....
07.07.26 - 16:45
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential? (Zacks)
 
AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer on key metrics....
07.07.26 - 14:36
2 Dirt Cheap Healthcare Stocks to Buy in July (24/7 Wall St.)
 
Healthcare has become Wall Street's bargain bin in 2026, and value hunters are starting to pay attention. Drug pricing reform, patent cliffs and post-COVID-19 hangovers have crushed multiples across Big Pharma, but the wreckage has created opportunities in two cash-generative franchises trading at single-digit forward earnings multiples. Heading into July, Novo Nordisk and Pfizer stand ... 2 Dirt Cheap Healthcare Stocks to Buy in July...
07.07.26 - 01:00
Pfizer (PFE) Stock Sinks As Market Gains: Here′s Why (Zacks)
 
Pfizer (PFE) concluded the recent trading session at $23.72, signifying a -2.47% move from its prior day's close....
06.07.26 - 13:54
Here Are Monday′s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More (24/7 Wall St.)
 
Pre-Market Stock Futures: Futures are trading mixed as we get ready to start the first full week of trading for the third quarter, as traders and investors return from the long 4th of July holiday. With second-quarter earnings starting this week, and with all of the major indices trading at or near all-time highs, you ... Here Are Monday's Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More...
03.07.26 - 08:09
Pfizer Buy (DPA-AFX)
 
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Pfizer mit einem Kursziel von 34 US-Dollar auf "Buy" belassen. Mit Blick auf Vorab-Aussagen des Pharmakonzerns zu den anstehenden Quartalszahlen hob Akash Tewari in einem am Freitag vorliegenden ......
01.07.26 - 16:24
Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy? (Fool)
 
These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals....
01.07.26 - 01:00
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors (Zacks)
 
Pfizer (PFE) closed at $24.08 in the latest trading session, marking a -1.19% move from the prior day....
01.07.26 - 00:01
Nike Appoints Pfizer CFO as New Finance Chief Amid Industry Experience Questions (Bloomberg)
 
Nina Trentmann, Senior Editor at Bloomberg News, discussed the recent appointment of Dave Denton, formerly Pfizer's CFO, as Nike's new Finance Chief. While some analysts have expressed concerns about Denton's lack of direct retail and apparel industry experience, Trentmann noted that for large companies like Nike and Pfizer, deep industry knowledge may be less critical than experience managing a complex, global business with a significant market capitalization and extensive supply chains. She speaks with Romaine Bostick & Katie Greifeld on "The Close." (Source: Bloomberg)...
30.06.26 - 18:18
Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat (24/7 Wall St.)
 
I keep buying Pfizer (NYSE:PFE) every time my brokerage cash builds up, and I am not slowing down. The market is treating this company like a value trap because COVID revenue is rolling off. I am treating it like a cash machine that just bought itself three extra years of patent life on one of ... Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat...
30.06.26 - 15:54
This 7% Yielding Healthcare Powerhouse Belongs in Retirees′ Portfolios (24/7 Wall St.)
 
Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE). The stock trades at $24.37, and the COVID franchise erosion has been brutal, with Comirnaty down 59% and Paxlovid down 63% in Q1 2026. Yet the dividend keeps coming. I want to know if that 7.27% yield is a gift or a warning. The Dividend ... This 7% Yielding Healthcare Powerhouse Belongs in Retirees' Portfolios...
30.06.26 - 15:24
Why Pfizer Could Prove to Be an Underrated GLP-1 Stock (Fool)
 
It could prove to be a case of better later than never for the healthcare giant....
29.06.26 - 18:12
3 No-Brainer Dividend Stocks to Buy Right Now (Fool)
 
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market....
29.06.26 - 13:15
Pfizer-Aktie: Darum ist sie jetzt ein klarer Kauf (Sharedeals)
 
Die Aktie des US-Pharmakonzerns Pfizer rückt nach einem Kursrücksetzer wieder stärker in den Fokus einkommensorientierter Anleger. Ausschlaggebend ist vor allem die außergewöhnlich hohe Dividendenrendite von derzeit rund 6,9 Prozent, mit der das Unternehmen deutlich über dem Durchschnitt des breiten US-Aktienmarktes liegt. Während der S&P 500 aktuell lediglich eine Dividendenrendite von rund 1,3 Prozent bietet, zählt […] The post Pfizer-Aktie: Darum ist sie jetzt ein klarer Kauf first appeared on sharedeals.de....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Bei einem großen Dichter hat man das Gefühl, als ob Dinge emportauchen, die im Chaos stecken geblieben sind. - Christian Friedrich Hebbel
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!